SANTA ROSA, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 first quarter financial results after market close on Wednesday, May 14, 2014. Company management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Wednesday May 14 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (844) 831-3024 for domestic callers, or (315) 625-6887 for international callers, or from the webcast on the investor relations section of the Company's Web site at: www.trivascular.com. The webcast will be available on the Company's Web site for 14 days following the completion of the call.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.
For more information visit www.trivascular.com